Your session is about to expire
← Back to Search
Meal Replacement System
Meal Replacement System for Type 2 Diabetes (DRS Trial)
N/A
Waitlist Available
Led By Warren Peters, MD
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline and six month visit.
Awards & highlights
DRS Trial Summary
This trial is testing a meal replacement system to see if it can help people with Type 2 Diabetes go into remission without the use of medications.
Who is the study for?
This trial is for English-speaking men and women aged 25-65 who have been diagnosed with non-insulin dependent Type 2 Diabetes within the last five years. Participants should be taking oral diabetes medication but not have had recent significant weight loss, bariatric surgery, or use of anti-obesity drugs.Check my eligibility
What is being tested?
The study tests a meal replacement system combined with an intensive lifestyle program over three months to see if it can lead to significant weight loss and help patients achieve diabetes remission without medication.See study design
What are the potential side effects?
Potential side effects may include nutritional deficiencies due to diet changes, gastrointestinal discomfort from new foods in the meal plan, and possible increased hunger or fatigue during the initial adjustment period.
DRS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change between baseline and six month visit.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline and six month visit.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Efficacy of plant-based meal replacement system on A1-C levels
Secondary outcome measures
Efficacy of plant-based meal replacement system on insulin levels
DRS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment2 Interventions
Replace meals with a plant-based meal replacement and self-prepared Meditteranean meals for a max 1200 calorie per day. Enroll in a 12 week intensive lifestyle intervention program.
Group II: Standard of Care GroupActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Loma Linda UniversityLead Sponsor
306 Previous Clinical Trials
260,955 Total Patients Enrolled
Warren Peters, MDPrincipal InvestigatorLoma Linda University Health
1 Previous Clinical Trials
100 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had weight loss surgery.You have taken medications for weight loss in the past three months.You have been diagnosed with an eating disorder.You are currently taking any kind of diabetes pill.You are currently receiving treatment for cancer.You are currently taking a pill for diabetes.You are taking medications that are known to cause weight gain, such as insulin, steroids, and certain psychiatric medications.You have tried to lose a lot of weight in the past 3 months.Your high blood pressure is not well controlled, with diastolic (bottom number) above 90 and systolic (top number) above 160.You must be between 25 and 65 years old.You have been diagnosed with non-insulin dependent diabetes for fewer than five years.You had a heart attack in the last 3 months.You have been diagnosed with non-insulin dependent diabetes for less than five years.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Group
- Group 2: Standard of Care Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Type 2 Diabetes Patient Testimony for trial: Trial Name: NCT05397028 — N/A
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger